# A Study of the Safety and Pharmacokinetics (PK) of MEHD7945A in Participants With Locally Advanced or Metastatic Epithelial Tumors

> **NCT01207323** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 66 (actual)

## Conditions studied

- Epithelial Tumors, Malignant

## Interventions

- **DRUG:** MEHD7945A

## Key facts

- **NCT ID:** NCT01207323
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11-09
- **Primary completion:** 2013-12-03
- **Final completion:** 2018-04-23
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2018-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01207323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01207323, "A Study of the Safety and Pharmacokinetics (PK) of MEHD7945A in Participants With Locally Advanced or Metastatic Epithelial Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01207323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*